Naoxintong/PPARγ Signaling Inhibits Cardiac Hypertrophy via Activation of Autophagy

As a traditional Chinese medicine, Naoxintong capsule (NXT) has been approved by China Food and Drug Administration (CFDA), which is used for cardiocerebrovascular disease treatment. Here we found that NXT extract significantly promoted H9c2 cardiomyocyte cell autophagy involved in increased autopha...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Shuping, Jin, Jianhua, Chen, Lu, Hou, Yongzhong, Wang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331281/
https://www.ncbi.nlm.nih.gov/pubmed/28293264
http://dx.doi.org/10.1155/2017/3801976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331281/
https://www.ncbi.nlm.nih.gov/pubmed/28293264
http://dx.doi.org/10.1155/2017/3801976

Ejemplares similares